Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | GILD | BMY | ||
| Company | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 463.74 | 129.13 | 54.61 | ||
| High | 472.24 | 133.10 | 55.53 | ||
| Low | 458.31 | 129.00 | 54.36 | ||
| Latest | 469.55 | 131.77 | 54.70 | ||
| Change | +8.41 | +2.66 | +0.20 | ||
| % Change | +1.82% | +2.06% | +0.37% | ||
| Volume | 655,137 | 4,472,845 | 5,688,896 | ||
| 20-Day Average Volume | 1,241,508 | 5,591,324 | 12,008,021 | ||
| Previous Close | 461.14 | 129.11 | 54.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 457.95 | 123.66 | 54.96 | ||
| 20-Day Raw Stochastic | 73.00% | 91.12% | 49.80% | ||
| 20-Day Relative Strength | 58.60 | 61.71 | 55.65 | ||
| Weighted Alpha | +10.97 | +40.33 | +0.54 | ||
| Today's Opinion | 80% Buy | 100% Buy | 80% Buy | ||
| Previous Opinion | 72% Buy | 96% Buy | 80% Buy | ||
| Last Month's Opinion | 72% Buy | 88% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.94% since 01/14/26 | +6.12% since 01/14/26 | -4.35% since 01/14/26 | ||
| Low | 429.00 on 01/20/26 | 120.94 on 01/15/26 | 53.54 on 01/21/26 | ||
| High | 472.04 on 01/22/26 | 133.10 on 01/22/26 | 57.00 on 01/15/26 | ||
| 1-Month | |||||
| %Chg | +2.48% since 12/22/25 | +6.04% since 12/22/25 | -0.22% since 12/22/25 | ||
| Low | 429.00 on 01/20/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 | ||
| High | 487.52 on 01/07/26 | 133.10 on 01/22/26 | 57.04 on 01/14/26 | ||
| 3-Month | |||||
| %Chg | +10.62% since 10/22/25 | +8.40% since 10/22/25 | +22.87% since 10/22/25 | ||
| Low | 403.16 on 11/04/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 | ||
| High | 487.52 on 01/07/26 | 133.10 on 01/22/26 | 57.04 on 01/14/26 | ||
| 6-Month | |||||
| %Chg | +0.34% since 07/22/25 | +19.51% since 07/22/25 | +13.58% since 07/22/25 | ||
| Low | 362.50 on 08/11/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 | ||
| High | 487.52 on 01/07/26 | 133.10 on 01/22/26 | 57.04 on 01/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 116,999,984 | 160,184,192 | 110,948,544 | ||
| Shares Outstanding, K | 253,719 | 1,240,680 | 2,035,753 | ||
| Annual Sales | 11,020,100,000 | 28,754,000,000 | 48,300,000,000 | ||
| Annual Net Income | -535,600,000 | 480,000,000 | -8,948,000,000 | ||
| Last Quarter Sales | 3,076,400,000 | 7,769,000,000 | 12,222,000,000 | ||
| Last Quarter Net Income | 1,082,900,000 | 3,052,000,000 | 2,201,000,000 | ||
| 60-Month Beta | 0.31 | 0.33 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 4.80 on 11/03/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 | ||
| Latest Earnings Date | 02/09/26 | 02/10/26 | 02/05/26 | ||
| Most Recent Dividend | N/A | 0.790 on 12/15/25 | 0.630 on 01/02/26 | ||
| Next Ex-Dividends Date | N/A | 12/15/25 | 01/02/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 28.88 | 15.16 | 8.27 | ||